Eisai
4523.T
23,00 €
Share price
0.84%
Change (1 day)
-37.55%
Change (1 year)
Categories
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.
Revenue for Eisai (4523.T)
Revenue in 2024 (TTM): €4.67 Billion
According to Eisai's latest financial reports the company's current revenue (TTM 
) is €4.46 Billion. In 2023 the company made a revenue of €4.78 Billion a decrease over the revenue in the year 2022 that were of €5.17 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Eisai from 2009 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 (TTM) | €4.67 B | -2.35% |
| 2023 | €4.78 B | -7.58% |
| 2022 | €5.17 B | -7.82% |
| 2021 | €5.61 B | 3.59% |
| 2020 | €5.42 B | 0.18% |
| 2019 | €5.41 B | 8.78% |
| 2018 | €4.97 B | 17.67% |
| 2017 | €4.22 B | -9.59% |
| 2016 | €4.67 B | 9.02% |
| 2015 | €4.29 B | 0.31% |
| 2014 | €4.27 B | -0.48% |
| 2013 | €4.29 B | -19.34% |
| 2012 | €5.32 B | -16.88% |
| 2011 | €6.41 B | -9.2% |
| 2010 | €7.06 B | 21.1% |
| 2009 | €5.83 B |